QuidelOrtho (QDEL) Cash from Investing Activities (2021 - 2026)
QuidelOrtho (QDEL) reported Cash from Investing Activities of -$34.0 million for Q1 2026, up 39.5% on a YoY basis from -$24.4 million in Q1 2025, and up 31.45% sequentially from -$49.6 million in Q4 2025.
QuidelOrtho (QDEL) Cash from Investing Activities (2021 - 2026) Analysis & Trends
QuidelOrtho (QDEL) has 6 years of Cash from Investing Activities data on file, last reported at -$34.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 39.5% year-over-year to -$34.0 million; the trailing twelve-month figure through Mar 2026 stood at -$170.5 million (up 8.28% YoY), and the FY2025 full-year result was -$192.7 million, down 28.55% from the prior year.
- Cash from Investing Activities rose to -$34.0 million in Q1 2026, from -$49.6 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$20.2 million in Q1 2024 to a low of -$1.4 billion in Q1 2023.
- A 5-year average of -$134.0 million and a median of -$42.3 million in 2023 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 96.12% in 2023, while the deepest fall reached 178.95% in 2023.
- Tracing QDEL's Cash from Investing Activities over 5 years: stood at -$24.7 million in 2022, then slumped by 123.08% to -$55.1 million in 2023, then jumped by 31.22% to -$37.9 million in 2024, then sank by 30.87% to -$49.6 million in 2025, then soared by 31.45% to -$34.0 million in 2026.
- Business Quant data shows QDEL's Cash from Investing Activities at -$34.0 million in Q1 2026, -$49.6 million in Q4 2025, and -$53.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | QuidelOrtho | 1.15 Bn | 1.01 Bn | - | -34.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -34.00 Mn |
| Mar 29, 2026 | -34.00 Mn |
| Dec 28, 2025 | -49.60 Mn |
| Dec 28, 2025 | -49.60 Mn |
| Sep 28, 2025 | -53.90 Mn |
| Sep 28, 2025 | -53.90 Mn |
| Jun 29, 2025 | -33.00 Mn |
| Jun 29, 2025 | -33.00 Mn |
| Mar 30, 2025 | -56.20 Mn |
| Mar 30, 2025 | -56.20 Mn |
| Dec 29, 2024 | -37.90 Mn |
| Dec 29, 2024 | -37.90 Mn |
| Sep 29, 2024 | -56.50 Mn |
| Sep 29, 2024 | -56.50 Mn |
| Jun 30, 2024 | -35.30 Mn |
| Jun 30, 2024 | -35.30 Mn |
| Mar 31, 2024 | -20.20 Mn |
| Mar 31, 2024 | -20.20 Mn |
| Dec 31, 2023 | -55.10 Mn |
| Dec 31, 2023 | -55.10 Mn |